Form 8-K - Current report:
SEC Accession No. 0000318306-13-000024
Filing Date
2013-11-27
Accepted
2013-11-27 16:01:32
Documents
1
Period of Report
2013-11-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K r8k-520.htm 8-K 15661
  Complete submission text file 0000318306-13-000024.txt   17032
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 131247867
SIC: 2834 Pharmaceutical Preparations